UNSPSC 51291507: Ebalzotan

This classification denotes a serotonin agonist and antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WV4B56N49H. European Medicines Agency schedules Ebalzotan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06434MIG. Ebalzotan generally arises in the molecular formula C19H30N2O2. The term EBALZOTAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, no. 3, 1995, list 35.) Most nations schedule ebalzotan under HS 29329985 and SITC 51569.

As of Q4 2014, EBALZOTAN remains the US FDA Preferred Term for this commodity. Ebalzotan bears US NLM identifiers UMLS ID C2348371 and NCI Concept Code C72746. SMILES: O1CC(N(C(C)C)CCC)Cc2c1cccc2C(=O)NC(C)C.

UNSPSC 51291507 Ebalzotan, a Commodity code, covers pharmaceutical products and medical supplies that state and local governments procure for public health and emergency response programs. The code appears to encompass naloxone, opioid antagonists, and related drug deactivation systems used in community health initiatives, overdose intervention, and substance-abuse response. State and local issuing bodies soliciting under this code include county health departments and public health agencies managing community health programs and emergency medical supply chains. The work involves competitive procurement of finished pharmaceutical products and medical devices for quarterly or regular distribution to public facilities.

Seminole County, Florida represents the primary recent activity under this code. In an IFB posted June 30, 2026 (IFB60459723LAS), Seminole County solicited 1,900 units of naloxone and 800 safe drug deactivation systems annually for delivery to the Seminole County Community Health Building in Sanford, Florida, with quarterly deliveries and a two-year initial term plus one-year renewal option. Vendors must submit bids electronically, include all shipping and delivery costs in pricing, comply with drug-free workplace and E-Verify requirements, and maintain workers' compensation, commercial general liability, and professional liability insurance. The procurement includes a three-month probationary termination clause and potential FEMA funding with attendant federal compliance obligations. No explicit set-aside restrictions are noted, and the contract will be awarded on a fixed-fee basis.